Secondary Logo

Journal Logo

January 2009 - Volume 32 - Issue 1
pp: 1-99

The Immune Adjuvant Properties of Front-line Carboplatin-Paclitaxel: A Randomized Phase 2 Study of Alternative Schedules of Intravenous Oregovomab Chemoimmunotherapy in Advanced Ovarian Cancer

Braly, Patricia; Nicodemus, Christopher F.; Chu, Christina; More

Journal of Immunotherapy. 32(1):54-65, January 2009.

Clinical Grade OK432-activated Dendritic Cells: In Vitro Characterization and Tracking During Intralymphatic Delivery

West, Emma; Morgan, Ruth; Scott, Karen; More

Journal of Immunotherapy. 32(1):66-78, January 2009.